Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludara in Untreated CLL with Anemia/Thrombocytopenia
NCT00220311Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2000
- Primary completion
- Sep 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 4, open-label, single-arm trial of fludarabine in chronic lymphocytic leukemia (CLL), sponsored by Sanofi. Primary endpoint: Overall Response Rate at 6 months. Started Nov 2000; status: completed.
02
Drugs
fludarabine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00220311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220311.